FELLOWSHIPS AND RESEARCH GRANTS ANNOUNCEMENT
ACADEMIC YEAR 2012-2013

The American Parkinson Disease Association will be accepting applications for the Medical Student Summer Fellowships for 2012. Applications are to be submitted electronically by January 31, 2012.

The American Parkinson Disease Association continues to fund for Research Grants, Postdoctoral Fellowships, the Cotzias Memorial Fellowships, the Roger Duvoisin Research Grants and Centers for Advanced Research.Please check back in the Fall of 2012 for new opportunities

You may contact Heather Duffy at 800 223-2732 ext. 117 or via email at hduffy@apdaparkinson.org for more information.

Medical Students Summer Fellowships

The APDA Summer Fellowships are designed to provide a stipend to enable medical students to perform supervised laboratory or clinical research designed to clarify our understanding of Parkinson’s disease, its nature, manifestations, etiology or treatment. It is hoped this experience will stimulate a student’s interest in future research in the field of Parkinson’s disease and related disorders.This is a Fellowship of $4,000 for a three(3) month summer commitment.

DeadLine

1/31/2012   Details

Fellowship Student Application


APDA Funded Research

George C. Cotzias, MD Memorial Fellowships

David Hinkle, MD, Ph.D.
University of Pittsburgh
Pittsburg, PA

The Potential Role of Antioxidant Systems in the Mechanism of DJ-1 Dependent Astrocytemediated Neuroprotection

 

Bradley Miller, MD, Ph.D.
University of Virginia
Charlottesville, VA

Distribution and Metabolic Consequences of Mitochondrial DNA Deletions in Substantia Nigra and Cultured Cells

 

Talene Yacoubian, MD, Ph.D.
The University of Alabama
Birmingham, Al

Role of 14-3-3 Proteins in Alpha Synuclein Induced Neurotoxicity

 

Roger C. Duvoisin, MD, Research Grant

Andrei Alexandrescu, Ph.D.
University of Connecticut
Storrs, CT

Stability and Solvent Accessibility of Alpha-Synuclein Fibrils by NMR Hydrogen Exchange

 

Jeffrey Stock, Ph.D.
Princeton University
Princeton, NJ

Protein Phosphatase 2A Methylation as a Therapeutic Target for Parkinson’s Disease

 

Marc Tatar, Ph.D.
Brown University
Providence, RI

Assessing the Pathogenic and Molecular Consequences of FOXO Regulation by Parkin

 

Research Grants

Hans Bueler, Ph.D.
University of Kentucky
Lexington, KY

Identification of PINK1 Substrates Using Conditional PINK1 Knockout Cells and Quantitative Phosphoproteomics

 

Ippolita Castelvetri, Ph.D.
Massachusetts General Hospital
Charlestown, MA

Biological Basis for Diferential Susceptibility to Alpha-Synuclein Pathology in the Male and Femal Human Brain

 

Savio Chan, Ph.D.
Northwestern University
Chicago, IL

Sriatopallidal GABAergic Signaling in Mouse Models of Parkinson’s Disease

 

Linan Chen, MD, Ph.D.
University of Chicago
Chicago, IL

Transgenic Overexpression Selectively in Dopamine Neurons via Controlled Genetic Amplification

 

Shu Chen, Ph.D.
Case Western Reserve University
Cleveland, OH

Transgenic C. Elegans Model of LRRK2-Linked Parkinson Disease

 

Shankar Chinta, Ph.D.
Buck Institute for Age Research
Novato, CA

Potential Neuroprotective Role of Resveratrol in Parkinson’s Disease Mouse Models

 

Paul Davenport, Ph.D.
University of Florida
Gainesville, FL

Central Neural Gating of Pharyngeal Mechanically Elicited Cortical Evoked Potentials (CEP): An Evaluation of Swallow Neural Integration in Parkinson’s Disease (PD)

 

Wei Ming Duan, MD, Ph.D.
Louisiana State University
Shreveport, LA

Generation of Dopaminergic Neurons from Endogenous Stem Cells in the Brain of a Mouse Model of Parkinson’s Disease

 

Jian Feng, Ph.D.
State University of New York
Buffalo, NY

Generating Patient –Specific Induced Pluripotent Stem Cells to Study Parkinson’s Disease

 

Matthew Goldberg, Ph.D.
UT Southwestern Medical Center
Dallas, TX

Parkin, DJ-1 and Glutathione Peroxidase-Deficient Mouse Models of PD

 

Steven Johnson, MD, Ph.D.
Portland VA Research
Portland, OR

Redox Regulation of NMDA Currents in Midbrain Dopamine Neurons

 

 

 

Gerardo Morfini, Ph.D.
University of Illinois
Chicago, IL

Molecular Mechanisms Underlying MPP+ Induced Activation of Cytoplamic Dynein-Based Vesicle Transport

 

Anthony Nicholas, MD, Ph.D.
University of Alabama
Birmingham, AL

Gene Analysis of Histone Deacetylation in Levodopa-Induced Dyskinesia and Priming

 

Arnulfo Quesada, Ph.D.
Brentwood Biomedical Research Institute
Los Angeles, CA

A Promising New Protective Factor for Parkinson’s Disease

 

 

Jean Rochet, Ph.D.
Purdue University
West Lafayette, IN

Role of ATP13A2 (PARK9) Dysfunction in Parkinson’s Disease

 

Subhojit Roy, Ph.D.
University of California
Jolla, CA

Effects of Alpha-Synuclein on Fast and Slow Axonal Transport

 

Derek Siebruth, Ph.D.
University of Southern California
Los Angeles, CA

Large Scale Analysis of Synaptic Architecture in Alphasynuclein Expressing Neurons

 

Wanli Smith, MD, Ph.D.
Johns Hopkins University School of Med.
Baltimore, MD

Autophagy and LRRK2-Linked Parkinsonism

 

Shaji Theodore, Ph.D.
University of Alabama
Birmingham, AL

Inhibiting Nuclear Factor Kappa B Signaling and Microglial Activation in a Mouse Model of Parkinson’s Disease

 

Enrique Torre, Ph.D.
Emory University
Atlanta, GA

Significance of mRNA Transport and Translation within the Dopaminergic Axon

 

Kala Venkiteswaran, Ph.D.
Penn State Hershey College of Medicine
Hershey, PA

Transplantation of Transdifferentiated Dopaminergic Neurons Derived from Human Retinal Pigment Epithelial Cells

 

Harrison Walker, MD
University of Alabama
Birmingham, AL

Bilateral Clinical and Neurophysiological Effects of Unilateral STN DBS in PD

 

Gaofeng Wang, Ph.D.
University of Miami
Coral Gables, FL

The Role of miRNA in Olfactory Deficit of Parkinson’s Disease

 

Andrew West, Ph.D.
University of Alabama
Birmingham, AL

Development of Cell Based Kinase Assays for LRRK2

 

 

Fu-Ming Zhou, MD, Ph.D.
University of Tennessee
Memphis, TN

An Ultra Short Dopamine Pathway: Part II. Signaling Mechanisms

 

Jianhui Zhu, Ph.D.
University of Pittsburgh
Pittsburgh, PA

ATP13A2 and Autolysosomal Pathology in Parkinson’s Disease

 

Xiongwei Zhu, Ph.D.
Case Western Reserve University
Cleveland, OH

Role of Impaired Mitochondrial Dynamics in Mutant LRRK2 Induced Toxicity

 

 

Post-Doctoral Fellowships

Jason Cannon, Ph.D.
University of Pittsburgh
Pittsburgh, PA

Genetic and Environmental Interactions in Parkinson’s Disease: Potential for New Therapeutic Pathways

 

William Caudle, Ph.D.
University of Washington
Seattle, WA

Proteomic Analysis of VMAT2 under Normal and Pathological Conditions

 

Yeun Su Choo, Ph.D.
Burnham Institute for Medical Research
La Jolla, CA

Regulation of Parkin by Neddylation

 

 

Gizem Donmez, Ph.D.
Massachusetts Institute of Technology
Cambridge, MA

Analysis of the Role of SIRT2 Protein in Parkinson’s Disease

 

Robert Drolet, Ph.D.
University of Pittsburgh
Pittsburgh, PA

Gastrointestinal Dysfunction in the Rotenone Model of Parkinson’s Disease

 

Muralidhar Hedge, Ph.D.
Uiversity of Texas
Galveston, TX

Role of Transition Metals in Inhibiting Repair of Oxidized Bases in Genome: Relevance to Parkinson’s Disease

 

William Lin, Ph.D.
University of Chicago
Chicago, IL

Mechanism and Function of Cytosolic PINK1

 

Zhihui Sun, Ph.D.
University of Pennsylvania
Philadelphia, PA

Investigating Synuclein Gene FunctionIn Zebrafish

 

Daniel Tardiff, Ph.D.
Whitehead Institute for Biomedical Res.
Cambridge, MA

Mitochondrial Proteomics of a Yeast Parkinson’s Disease Model

 

Ravindar Thomas, Ph.D.
University of Virginia
Charlottesville, VA

Development of Mitochondrial Gene Therapy for Parkinson’s Disease

 

Yulan Xiong, Ph.D.
Johns Hopkins University
Baltimore, MD

Modeling LRRK2-Induced Toxicity in Yeast

 

Nanyan Zhang, Ph.D.
University of Colorado
Aurora, CO

Delineating Protein Coaggregation during Lewy Body Formation

 

Medical Students Summer Fellowships

Grant Aaker
Weill Cornell Medical College
New York, NY

Detection of Retinal Changes in PD with Optical Coherence

 

Shivraj Bhosle
Burke Medical Research Institute/Weill Cornell Medical College
New York, NY

Region Specific Regulation of Gene Expression in Dopamine Neurons

 

Nirmish Singla
University of Michigan Medical School
Ann Arbor, MI

Evaluation of Lead Placement in Deep Brain Stimulation with Post-op Cognitive and Behavioral Outcome

 

Minhong Yu
University of Virginia
Charlottesville, NC

Rhythmic Perception in Parkinson Disease

 

 

 

Centers for Advanced Research

University of Alabama
David Standaert, MD
Birmingham, AL

UCLA School of Medicine
Marie Francois Chesslet, MD, PhD
Los Angeles, CA

 

Emory University School of Medicine
Mahlon DeLong, MD
Atlanta, GA

The University of Chicago
Un Jung Kang, MD
Chicago, IL

 

Boston University School of Medicine
Marie St. Hilaire, MD
Boston, MA

Washington University Medical Center
Joel Perlmutter, MD
St. Louis, MO

 

Robert Wood Johnson Medical School
Jacob Sage, MD
New Brunswick, NJ

University of Pittsburgh
J. Timothy Greenamyre, MD, PhD
Pittsburgh, PA

 

University of Virginia Medical Center
Frederick G. Wooten, MD
Charlottesville, VA